The U.K. was the first Western nation to start a mass vaccination campaign and now it’s testing a mix and match strategy for inoculations.

There are 820 participants in the trial who will get an AstraZeneca primer, followed by a Pfizer-BioNTech booster, while others will get the opposite and some could get two of the same shot, the current standard practice. Some health experts say the results could bolster the fight against the pandemic.

Crystal Goomansingh reports on how the trial could not only bolster the vaccine strategy but also potentially lead to enhanced immunity.

For more info, please go to https://globalnews.ca/news/7724407/canada-vaccine-mixing-uk-study/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #covid19 #Coronavirus